Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avastin plus taxane in advanced breast cancer
NCT00448591Phase 3Completed
- Sponsor
- Roche
- Start
- Sep 2006
- Primary completion
- Feb 2013
- Modality
- Monoclonal Antibodies
- Countries
- 36
01
Overview
A Phase 3 trial of bevacizumab in breast cancer, sponsored by Roche. Started Sep 2006; status: completed.
02
Drugs
bevacizumab
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00448591.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00448591.